141 results on '"Koch, Martin C."'
Search Results
2. Cervical intraepithelial neoplasia grade 3: development during pregnancy and postpartum
3. Revidierte Fassung der S3-Leitlinie Zervixkarzinom 2021 – Anforderungen an die Pathologie
4. Human papilloma virus genotype distribution in women with premalignant or malignant lesions of the uterine cervix
5. Vulvakarzinom: onkochirurgische Therapie und rekonstruktive Möglichkeiten
6. Concordance rate of vulvoscopic findings in detecting early vulvar neoplasia
7. Impact of the Corona Pandemic on Cervical Cancer Screening Assessment
8. Operative Therapie des Zervixkarzinoms
9. Accuracy of colposcopic findings in detecting vaginal intraepithelial neoplasia: a retrospective study
10. Correlation between referral cytology and in-house colposcopy-guided cytology for detecting early cervical neoplasia
11. Cytology and HPV Co-Testing for Detection of Vaginal Intraepithelial Neoplasia: A Retrospective Study
12. Neoadjuvante Therapiekonzepte beim Zervixkarzinom
13. Accuracy of colposcopy-directed biopsy in detecting early cervical neoplasia: a retrospective study
14. Standardized Procedures for Patients with Dysplasia and Other Diseases of the Cervix, Vulva, and Vagina at a Certified Dysplasia Unit Prior to the Introduction of the Organized Cervical Cancer Screening Program
15. Management of Cervical Intraepithelial Neoplasia in Pregnant Women
16. Gestational and Non-gestational Trophoblastic Neoplasia. Guideline of the DGGG, OEGGG and SGGG (S2k-Level, AWMF Registry No. 032/049, April 2022)
17. Revidierte Fassung der S3-Leitlinie Zervixkarzinom 2021 – Anforderungen an die Pathologie
18. Clarifications concerning the commentary “Published analysis of contraceptive effectiveness of Daysy and DaysyView app is fatally flawed”
19. Cervical intraepithelial neoplasia grade 3: development during pregnancy and postpartum
20. Concordance Rate of Colposcopy in Detecting Cervical Intraepithelial Lesions
21. RETRACTED ARTICLE: Improving usability and pregnancy rates of a fertility monitor by an additional mobile application: results of a retrospective efficacy study of Daysy and DaysyView app
22. Moderne systemische Therapiekonzepte beim Zervixkarzinom: Neuerungen aus der S3-Leitlinie „Diagnostik, Therapie und Nachsorge der Patientin mit Zervixkarzinom“
23. Cytology and High-Risk Human Papillomavirus Test for Cervical Cancer Screening Assessment
24. Diagnosis, Therapy and Follow-up of Cervical Cancer Guideline of the DGGG, DKG and DKH (S3-Level, AWMF Registry No. 032/033OL, May 2021) - Part 1 with Recommendations on Epidemiology, Screening, Diagnostics and Therapy
25. Diagnosis, Therapy and Follow-up of Cervical Cancer Guideline of the DGGG, DKG and DKH (S3-Level, AWMF Registry No. 032/033OL, May 2021) - Part 2 with Recommendations on Psycho-oncology, Rehabilitation, Follow-up, Recurrence, Palliative Therapy and Healthcare Facilities
26. RANKL and OPG and their influence on breast volume changes during pregnancy in healthy women
27. Diagnosis, Therapy and Follow-up of Cervical Cancer. Guideline of the DGGG, DKG and DKH (S3-Level, AWMF Registry No. 032/033OL, May 2021) – Part 1 with Recommendations on Epidemiology, Screening, Diagnostics and Therapy
28. Prevalence of SARS-CoV-2 in Pregnant Women Assessed by RT-PCR in Franconia, Germany: First Results of the SCENARIO Study (SARS-CoV-2 prEvalence in pregNAncy and at biRth In FrancOnia)
29. The global pandemic and changes in women’s reproductive health: an observational study
30. Risk for Pelvic Metastasis and Role of Pelvic Lymphadenectomy in Node-Positive Vulvar Cancer-Results from the AGO-VOP.2 QS Vulva Study
31. Breast Volumetry Using a Three-Dimensional Surface Assessment Technique
32. The Prevention of Positioning Injuries During Gynecologic Surgery. Guideline of the DGGG, OEGGG and SGGG (S2k Level, AWMF Registry Number 015/077, October 2020)
33. Introducing a novel highly prognostic grading scheme based on tumour budding and cell nest size for squamous cell carcinoma of the uterine cervix
34. The performance of a fertility tracking device
35. Neoadjuvante Chemotherapiekonzepte beim Zervixkarzinom
36. Correlation between referral cytology and in-house colposcopy-guided cytology for detecting early cervical neoplasia
37. Diagnosis, Therapy and Follow-up of Vaginal Cancer and Its Precursors. Guideline of the DGGG and the DKG (S2k-Level, AWMF Registry No. 032/042, October 2018)
38. Primäre Prävention – Mamma- und Genitalkarzinome
39. Diagnosis, Therapy and Follow-up of Vaginal Cancer and Its Precursors. Guideline of the DGGG and the DKG (S2k-Level, AWMF Registry No. 032/042, October 2018)
40. Retraction Note: Improving usability and pregnancy rates of a fertility monitor by an additional mobile application: results of a retrospective efficacy study of Daysy and DaysyView app
41. Accuracy of colposcopy-directed biopsy in detecting early cervical neoplasia: a retrospective study
42. Primäre Prävention – Mamma- und Genitalkarzinome.
43. Krebsfrüherkennung des weiblichen Genitales.
44. Benigne Veränderungen der Vulva.
45. Computer-assisted diagnosis (CAD) in colposcopy: Evaluation of a pilot study
46. Diagnostik und Therapie des Vulvakarzinoms: Leitlinienkonformes Vorgehen und interdisziplinäre Zusammenarbeit.
47. Antiangiogenese verlängert das Überleben beim Zervixkarzinom
48. HIV-associated Hypertrophic Herpes Simplex Genitalis With Concomitant Early Invasive Squamous Cell Carcinoma Mimicking Advanced Genital Cancer
49. Improving usability and pregnancy rates of a fertility monitor by an additional mobile application: results of a retrospective efficacy study of Daysy and DaysyView app.
50. Diagnosis, Therapy and Follow-up of Cervical Cancer. Guideline of the DGGG, DKG and DKH (S3-Level, AWMF Registry No. 032/033OL, May 2021) - Part 2 with Recommendations on Psycho-oncology, Rehabilitation, Follow-up, Recurrence, Palliative Therapy and Healthcare Facilities.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.